Trazodone for the treatment of neuroleptic-induced acute akathisia: A placebo-controlled, double-blind, crossover study

Clinical Neuropharmacology

Volumn 33, Issue 5, 2010, Pages 219-222

  Stryjer, Rafael ^a,b   Rosenzcwaig, Silvio ^a,b   Bar, Faina ^a,b   Ulman, Ann Marie ^a,b   Weizman, Abraham ^b,c   Spivak, Baruch ^a,b  

^a NESS ZIONA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c GEHA MENTAL HEALTH CENTER   (Israel)

Author keywords

akathisia; serotonin; trazodone

Indexed keywords

NEUROLEPTIC AGENT; TRAZODONE;

ADULT; AKATHISIA; ARTICLE; BEDTIME DOSAGE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DISTRESS SYNDROME; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; INCIDENCE; MALE; NEUROLEPTIC INDUCED ACUTE AKATHISIA; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TRAZODONE; TREATMENT OUTCOME;

EID: 77957996301     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e3181ee7f63     Document Type: Article

References (28)

1. Poyurovsky M, Shardorodsky M, Weizman A. Treatment of neuroleptic-induced akathisia with 5-HT2 antagonist mianserin. Double-blind, placebo-controlled study. Br J Psychiatry 1999;174: 238Y242.
2. Fleischhacker WW, Roth SD, Kane JM. The pharmacological treatment of neuroleptic-induced akathisia. J Clin Psychopharmacol 1990;10:12Y21.
3. Poyurovsky M, Weizman A. Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem. Br J Psychiatry 2001;179:4Y8.
4. Kumar R, Sachdev PS. Akathisia and second-generation antipsychotic drugs. Curr Opin Psychiatry 2009;22(3):293Y299.
5. Kim J-H, Byum H-J. Prevalence and characteristic of subjective akathisia, objective akathisia and mixed akathisia in chronic schizophrenic patients. Clin Neuropharmacol 2003;26:312Y316.
6. Miller GH, Fleischhacker WW, Ehrman H, et al. Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin. Psychopharmacol Bull 1990;26:373Y376.
7. Kapur S, Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 1999;153:466Y476.
8. Meltzer HY. The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 1999;21:106SY115S.
9. Lane RM. SSRI-induced extrapyramidal side-effects and akathisia: implication for treatment. J Psychopharmacol 1998;12:192Y214.
10. Poyurovsky M, Weizman A. Mirtazapine for neuroleptic-induced akathisia. Am J Psychiatry 2001;158:819.
11. Poyurovsky M, Pashiniam A, Weizman R, et al. Low dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. Biol Psychiatry 2006;59:1071Y1077.
12. Miller CH, Hummer M, Pycha R, et al. The effect of ritanserin on treatment-resistant neuroleptic induced akathisia: case reports. Prog Neuropsychopharmacol Biol Psychiatry 1992;16: 247Y251.
13. Poyurovsky M, Shardorodsky M, Fuchs C, et al. Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist mianserin. Br J Psychiatry 1999;174:238Y242.
14. Weiss D, Aizenberg D, Hermesh H, et al. Cyproheptadine treatment in neuroleptic-induced akathisia. Br J Psychiatry 1995;167:483Y486.
15. Fischel T, Hermesh H, Aizenberg D, et al. Cyproheptadine vs propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study. J Clin Psychopharmacol 2001;21(6):612Y615.
16. Poyurovsky M, Epshtein S, Fuchs C, et al. Efficacy of low dose mirtazapine in neuroleptic induced akathisia: a double blind randomized placebo-controlled pilot study. J Clin Psychopharmacol 2003;23:305Y308.
17. Avital A, Gross Isseroff R, Stryjer R, et al. Zolmitriptan compared to propranolol in the treatment of acute induced neuroleptic-induced akathisia: a comparative double-blind study. Eur Neuropsychopharmacol 2009;19:476Y482.
18. Sadock BJ, Sadock VA. Kaplan and Sadock's Comprehensive Textbook of Psychiatry. 10th ed. Philadelphia, PA: LippincottWilliams &Wilkins; 2007:994.
19. Wiegand MH. Antidepressants for the treatment of insomnia: a suitable approach. Drugs 2008;68:2411Y2417.
20. MeinhardtW, Schmitz PI, Kropman RF, et al. Trazodone, a double blind trial for treatment of erectile dysfunction. Int J Impot Res 1997;9:163Y165.
21. Stryjer R, Strous RD, Bar F, et al. Treatment of neuroleptic-induced akathisia with the 5HT2a antagonist trazodone. Clin Neuropharmacol 2003;26:137Y141.
22. Barnes TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672Y676.
23. Simpson GM, Angus JWS. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand 1970;212(suppl):11Y19.
24. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261Y276.
25. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56Y62.
26. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, NJ: Lawrence Earlbaum Associates; 1988.
27. Medina CA. Clitoral priapism: a rare condition presenting as a cause of vulvar pain. Obstet Gynecol 2001;97:26Y27.
28. Thompson JW Jr, Ware MR, Blashfield RK. Psychotropic medication and priapism: a comprehensive review. J Clin Psychiatry 1990;51:430Y433.